KU-0059436
Showing 51 - 75 of 86
Triple Negative Breast Tumors Trial in Worldwide (Pembrolizumab, Olaparib, Carboplatin)
Active, not recruiting
- Triple Negative Breast Neoplasms
- Pembrolizumab
- +3 more
-
Monterey, California
- +121 more
Oct 10, 2022
Advanced Adrenal Gland Pheochromocytoma, Advanced Paraganglioma, Metastatic Adrenal Gland Pheochromocytoma Trial in United
Recruiting
- Advanced Adrenal Gland Pheochromocytoma
- +5 more
- Olaparib
- +2 more
-
Anchorage, Alaska
- +153 more
Aug 23, 2022
Head and Neck Squamous Cell Carcinoma Trial in France, Taiwan, United States (Ceralasertib, Olaparib)
Completed
- Head and Neck Squamous Cell Carcinoma
-
Pittsburgh, Pennsylvania
- +3 more
Aug 9, 2021
Systemic Lupus Erythematosus Trial in Sohag (Anti _KU antibodies)
Recruiting
- Systemic Lupus Erythematosus
- Anti _KU antibodies
-
Sohag, EgyptSohag University Hospitals
Jun 8, 2023
Breast Inflammatory Carcinoma Trial in Canada, Puerto Rico, United States (Olaparib, Radiation Therapy)
Recruiting
- Breast Inflammatory Carcinoma
- Olaparib
- Radiation Therapy
-
Anchorage, Alaska
- +183 more
Aug 20, 2022
Advanced Malignant Solid Tumor, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma Trial in
Recruiting
- Advanced Malignant Solid Neoplasm
- +44 more
- Biopsy
- +23 more
-
Birmingham, Alabama
- +166 more
Feb 2, 2023
Lung Tumors, NSCLC Trial in Worldwide (biological, drug, radiation)
Recruiting
- Lung Neoplasms
- Carcinoma, Non-Small-Cell Lung
- Pembrolizumab
- +9 more
-
Mobile, Alabama
- +194 more
Aug 18, 2022
Gout Trial (HKIIM-KU formula, Placebo)
Not yet recruiting
- Gout
- HKIIM-KU formula
- Placebo
- (no location specified)
Aug 10, 2022
NSCLC Trial in United Kingdom (Olaparib, Placebo)
Unknown status
- Non-small Cell Lung Cancer
- Olaparib
- Placebo
-
Blackpool, United Kingdom
- +19 more
Oct 24, 2018
Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Serous Adenocarcinoma Trial
Active, not recruiting
- Fallopian Tube Clear Cell Adenocarcinoma
- +14 more
- Cediranib
- +9 more
-
Birmingham, Alabama
- +399 more
Dec 30, 2022
Pancreatic Acinar Cell Carcinoma, Pancreatic Adenosquamous Carcinoma, Pancreatic Squamous Cell Carcinoma Trial in United States
Recruiting
- Pancreatic Acinar Cell Carcinoma
- +6 more
- Biospecimen Collection
- +4 more
-
Anchorage, Alaska
- +357 more
Jan 28, 2023
Fallopian Tube Mucinous Adenocarcinoma, Ovarian Seromucinous Carcinoma, Platinum-Refractory Fallopian Tube Carcinoma Trial in
Recruiting
- Fallopian Tube Mucinous Adenocarcinoma
- +49 more
- Cediranib Maleate
- +5 more
-
Anchorage, Alaska
- +373 more
Aug 17, 2022
Breast Cancer, Hereditary Diseases Trial in Leuven (Blood draw, Post-mortem tissue collection)
Recruiting
- Breast Cancer
- Hereditary Diseases
- Blood draw
- Post-mortem tissue collection
-
Leuven, BelgiumUZ Leuven
Mar 29, 2021
Metastatic Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in United States (Olaparib, Pembrolizumab)
Recruiting
- Metastatic Pancreatic Adenocarcinoma
- Stage IV Pancreatic Cancer AJCC v8
- Olaparib
- Pembrolizumab
-
Anchorage, Alaska
- +513 more
Jan 28, 2023
Health Trial in Leuven (VIPUN Gastric Monitoring System prototype)
Completed
- Health
- VIPUN Gastric Monitoring System prototype
-
Leuven, BelgiumUZ Leuven
Sep 29, 2021
System in Early Detection of Gastric Cancer in France. Cancer in
Recruiting
- Gastric Cancer
- Evaluation of the proportion of gastric neoplastic lesions detected by a computer-aided diagnosis system (CADx) compared with experienced endoscopists.
-
Lyon, FranceHôpital Edouard Herriot
Jun 23, 2023
Endometrial Undifferentiated Carcinoma, Endometrioid Adenocarcinoma, Recurrent Endometrial Serous Adenocarcinoma Trial in United
Recruiting
- Endometrial Undifferentiated Carcinoma
- +6 more
- Capivasertib
- +4 more
-
Birmingham, Alabama
- +741 more
Feb 2, 2023
Survivorship, Late Effect Trial in Genoa (Survivorship passport (SurPass) delivery)
Not yet recruiting
- Survivorship
- Late Effect
- Survivorship passport (SurPass) delivery
-
Genoa, ItalyIstituto Giannina Gaslini
Aug 7, 2023
Heart Failure Trial in Rio De Janeiro (telemedicine-guided consultation)
Recruiting
- Heart Failure
- telemedicine-guided consultation
-
Rio De Janeiro, BrazilInstituto Nacional de Cardiologia Laranjeiras
Jul 3, 2021
Lactate for Energy and Neurocognition
Not yet recruiting
- Healthy Aging
- Alzheimer Disease
-
Kansas City, KansasUniveristy of Kansas Medical Center
Jan 31, 2022
Urinary Incontinence, Mobility Impairment, Older Adults Trial in Bern (VITAAL Exergame, Conventional Training UI, Conventional
Recruiting
- Urinary Incontinence
- +2 more
- VITAAL Exergame
- +2 more
-
Bern, Interlaken, SwitzerlandPhysio SPArtos
Mar 1, 2021
Occupational Health, Screening, Surveys and Questionnaires Trial in Belgium (Electronic survey with selective consultations)
Completed
- Occupational Health
- +2 more
- Electronic survey with selective consultations
-
Leuven, Flanders, Belgium
- +3 more
Jan 25, 2021